| 产品详情 |
| Edit |   |
|---|
| Product Name | Beta Amyloid 1- 42 (Aβ42) Ligand Screening Assay Kit (Fluorometric) |
|---|
| Description | Alzheimer's disease is a chronic neurodegenerative disease. It is caused by accumulation of amyloid plaques that can be found in the brains of patients suffering this condition. Plaques are mainly composed of Beta amyloid (Aβ) peptides: Aβ (1-40) and Aβ (1-42). Recent studies showed that two Beta Amyloid peptides (Aβ (1-40) and Aβ (1-42)) exist in brain tissues, cerebrospinal fluid (CSF) and plasma in patients suffering from Alzheimer's disease. In particular, aggregated Aβ (1-42) is considered a validated biomarker for diagnosing Alzheimer's disease. Therefore, screening Aβ42 Ligands that could prevent aggregation is critical for developing potential therapeutic treatments. In BioVision's Beta Amyloid 1-4 |
|---|
| Size | 100 assays |
|---|
| Concentration | n/a |
|---|
| Applications | • Rapid, high-throughput screening of drugs and novel ligands. • Development of structure-activity relationship (SAR) models to predictAβ42/ligand interaction liability of novel compounds. |
|---|
| Other Names | n/a |
|---|
| Gene, Accession, CAS # | n/a |
|---|
| Catalog # | K570-100 |
|---|
| Price | |
|---|
| Order / More Info | Beta Amyloid 1- 42 (Aβ42) Ligand Screening Assay Kit (Fluorometric) from BIOVISION, INC. |
|---|
| Product Specific References | n/a |
|---|
| 产品资料 |
|
|